Iver Larson was Appointed as Associate General Counsel, Healthcare and Commercial Law at Seattle-Genetics

Date of management change: August 16, 2018 

What Happened?

Bothell, -based Seattle-Genetics Appointed Iver Larson as Associate General Counsel, Healthcare and Commercial Law


About the Company

Targeting Cancer. Transforming Therapies. Revolutionary science meets transformative cancer therapy Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. The largest global oncology biotechnology company based in the Pacific Northwest, we are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer. Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients. ADCs are an integral part of the evolving cancer treatment paradigm with their specificity, stability and potency. In addition to one marketed product, we are advancing a strong product pipeline designed to address significant unmet medical needs.


About the Person

Iver Larson is Associate General Counsel, Healthcare and Commercial Law at Seattle Genetics. Previously, Iver held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Bennett Rebekah, Soucie Christopher, McDonald Benjamin, Bauer Michael, Barrett Lucretia, Nuechterlein Carole, Hilke Catherine, Manderscheid David, Proch Lisa, Poole Jill, Clements Nicholas

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.